We use cookies

Essential storage keeps the site working (sign-in, theme, this choice). We'd also like to load Google Analytics to understand, in aggregate, how the site is used — never your genetic data. See our Cookie Policy.

SLC22A12 rs17426219: Uric Acid Regulation & Gout Predisposition

rs17426219
Health Predisposition
Limited evidenceGene: SLC22A12

The genetic variant rs17426219 is a single nucleotide polymorphism located in the SLC22A12 gene, which codes for the essential renal transporter protein URAT1. Research links this variant to modest variations in circulating serum uric acid levels and differential predispositions to hyperuricemia and gout. While urate transport biology is well characterized, the clinical effect size of this individual variant remains limited and varies noticeably across different ancestral populations.

What each genotype means

A/ALower attention

Typical urate transporter activity

This genotype represents the most common form of the SLC22A12 gene in many populations. It is associated with standard function of the URAT1 protein, which helps regulate uric acid levels in the blood. This result does not indicate a specific predisposition to hyperuricemia or gout.

This is the most common genotype in most global populations, though frequency varies significantly by ancestry.

A/GModerate attention

Potential altered urate transport

Carrying one copy of the variant allele may be associated with subtle differences in how your kidneys reabsorb uric acid. Research into this specific variant is limited, and its clinical significance regarding gout or hyperuricemia remains uncertain. Please discuss your overall metabolic health and any concerns about uric acid levels with your healthcare provider.

This genotype is observed at a minor allele frequency of approximately 0.08 in East Asian populations and is considered rare in European cohorts.

G/GModerate attention

Increased urate transport association

This genotype is associated with the variant allele that has been linked in some studies to altered serum uric acid levels. Because the evidence for this specific variant is limited, it is not a diagnostic indicator of disease. You should consult with a clinician to interpret this finding in the context of your personal health history and blood test results.

This genotype is rare, occurring at a low frequency in East Asian populations and is very uncommon in individuals of European ancestry.

Genomic Location and Variant Biology

The single nucleotide polymorphism rs17426219 represents a specific variation on human chromosome 11 within the solute carrier family 22 member 12 gene (SLC22A12). As documented in foundational genomic repositories such as dbSNP and Ensembl, variations in this locus alter genomic sequence architecture within regions regulating urate transport machinery. The SLC22A12 gene provides instructions for building urate transporter 1 (URAT1), an integral membrane protein situated on the apical brush-border membrane of proximal kidney tubules. Variants across this gene can influence transcriptional efficiency, mRNA stability, or the physical structure of the transporter, directly modulating the reabsorption of urate filtered from circulation back into blood vessels.

The Biological Function of URAT1 in Uric Acid Homeostasis

Uric acid is the final metabolic byproduct of purine nucleotide degradation in humans, and systemic levels depend heavily on renal clearance. As summarized by MedlinePlus Genetics, URAT1 acts as a primary organic anion exchanger responsible for renal urate reabsorption. When functioning typically, URAT1 reclaims a substantial portion of filtered uric acid from proximal tubule lumens back into renal tubular cells. Major loss-of-function mutations across SLC22A12 severely impair reabsorption, leading to rare conditions such as idiopathic renal hypouricemia. Common single nucleotide polymorphisms such as rs17426219, however, exert much milder physiological adjustments, slightly shifting the homeostatic equilibrium between excreted and reabsorbed urate in the renal parenchyma.

Scientific Research and Gout Predisposition

Genome-wide association studies (GWAS) and candidate gene analyses indexed in PubMed and the GWAS Catalog have examined SLC22A12 polymorphisms for their links to serum uric acid concentrations and clinical gout. Elevated systemic urate can lead to crystal precipitation in synovial joints, causing acute inflammation. Research demonstrates that rs17426219 correlates with baseline serum urate concentrations, altering statistical risk for developing hyperuricemia. However, the direct correlation between common SLC22A12 polymorphisms and clinical gout displays marked heterogeneity across cohorts. While nonfunctional loss-of-function alleles produce profound protective hypouricemia, common regulatory SNPs like rs17426219 demonstrate modest statistical influence, indicating that environmental inputs and multi-locus genetic architecture predominantly shape systemic disease progression.

Population Distribution and Ancestral Patterns

Allelic distributions for rs17426219 demonstrate marked geographic and ancestral divergence across reference datasets such as gnomAD. In East Asian cohorts, the minor allele frequency is observed at approximately 0.08, making it a moderately common variant within these populations. Conversely, the minor allele is exceptionally rare in European ancestral cohorts, with frequencies routinely measured below 0.01. Because of these distinct frequency patterns, genomic association studies investigating uric acid transport variants frequently observe ancestral divergence in disease mapping. A variant that plays an identifiable role in East Asian association panels may have negligible clinical or investigative utility in European cohorts simply because it occurs too infrequently.

Navigating Results: What This Information Means for You

Discovering an altered genotype at rs17426219 does not constitute a clinical diagnosis of hyperuricemia, renal stones, or gout, nor does it guarantee you will remain free from these conditions. Single nucleotide polymorphisms confer small statistical probabilities rather than absolute physiological outcomes. Real-world serum uric acid levels are driven by complex polygenic networks—including variants in ABCG2 and SLC2A9—combined with nutritional factors, alcohol intake, body composition, and kidney function. If you have concerns regarding elevated uric acid or joint pain, direct lab measurements of serum urate are far more clinically definitive than individual genotype markers. Any discussions regarding preventative measures, pharmacotherapies, or dietary modifications should always be directed to a qualified healthcare provider.

How common is this variant?

The minor allele exhibits marked ancestral divergence, with a frequency of approximately 0.08 in East Asian populations while remaining rare in European cohorts (<0.01).

Frequently asked questions

Does having the rs17426219 variant mean I will get gout?

No, carrying this variant does not mean you will develop gout. The SNP rs17426219 confers only a minor statistical influence on serum uric acid concentrations rather than a deterministic disease outcome. Most individuals who carry this variant never experience clinical gout flares.

Can rs17426219 testing replace a standard uric acid blood test?

No, genetic variant testing cannot replace a direct serum uric acid test. A blood draw reflects your real-time physiological urate level, integrating dietary purines, metabolic health, and multi-organ clearance. Clinicians rely on biochemical lab values rather than single-gene genetic tests to evaluate hyperuricemia.

How does SLC22A12 affect uric acid in the kidneys?

The SLC22A12 gene codes for the URAT1 protein, which resides on the surface of proximal kidney tubules. URAT1 functions as a molecular gate that reabsorbs filtered urate from urine back into the bloodstream. Genetic variants in this gene can alter the efficiency of this reabsorption process.

Why is rs17426219 more common in East Asian populations?

Human populations accumulate different allele frequencies over millennia through genetic drift, historical migration, and regional evolutionary pressures. In public genomic databases like gnomAD, rs17426219 shows a minor allele frequency around 8% in East Asian cohorts, whereas it is almost absent in European lineages.

Should I change my diet based on my rs17426219 genotype?

You should not make drastic dietary adjustments solely on the basis of a single genetic variant. While purine-rich foods and alcohol can impact systemic urate levels, lifestyle interventions should be guided by your actual medical history and measured blood chemistry. Consult a physician or registered dietitian for personalized guidance.

Sources & further reading

Educational information only, last refreshed 9/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.

Curious what your genotype is for rs17426219?

Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.

Get my report — $29

Related variants in SLC22A12